J Mitra & Co Pvt

J Mitra & Co. is pioneer in manufacturing of in-vitro diagnostics Kits and Reagents in India. The Company focuses on preserving human lives, by promoting healthcare through technology and innovation. Incorporated in 1969, this research-based biotechnology company will soon complete 50 years towards its mission to serve mankind. Apart from a pan-India footprint, we are also the biggest exporter of diagnostics kits from India, and export to more than 40 countries across the entire globe. It is the tradition of quality and seriousness of purpose that has led to a sterling and harmonious growth and an enviable recognition that extended far beyond its frontiers. The company manufactures a range of tests for infectious diseases like HIV, HBV, HCV, Dengue, Malaria, Typhoid, Leptospira in rapid and ELISA test formats. The other products include a range of anti-Sera products and confirmatory tests like Western Blot for HIV Some of Our Industry Firsts  Maximum patents in India – more than 55 patents  First Indian Company to get drug manufacturing licenses for critical tests in both rapid and Elisa formats like HIV, HBV, HCV  Introduced the technology of differential detection of HIV 1 and HIV 2 in single rapid kit format, a product which still is the market leader after two decades.  Dengue Day 1 test (world-class IVD product) which have achieved no. 1 market share after its launch in 2010  Recently introduced Fluorescence Immunoassay technology for quantitative and qualitative range of tests. The company manufactures HbA1c, Vitamin D, T3, T4, TSH and Dengue NS1 in FIA (Fluorescence immunoassay) range. These tests can be performed on state of the art analyser called i-Quant, developed in partnership with HTIC, IIT Madras. Awards & Recognitions  “India’s Patent King” to its chairman Mr Lalit Mahajan

Biotechnology
Ahmedabad, Gujarat
Founded in unknown
51-200 employees

J Mitra & Co. is pioneer in manufacturing of in-vitro diagnostics Kits and Reagents in India. The Company focuses on preserving human lives, by promoting healthcare through technology and innovation. Incorporated in 1969, this research-based biotechnology company will soon complete 50 years towards its mission to serve mankind. Apart from a pan-India footprint, we are also the biggest exporter of diagnostics kits from India, and export to more than 40 countries across the entire globe. It is the tradition of quality and seriousness of purpose that has led to a sterling and harmonious growth and an enviable recognition that extended far beyond its frontiers. The company manufactures a range of tests for infectious diseases like HIV, HBV, HCV, Dengue, Malaria, Typhoid, Leptospira in rapid and ELISA test formats. The other products include a range of anti-Sera products and confirmatory tests like Western Blot for HIV Some of Our Industry Firsts  Maximum patents in India – more than 55 patents  First Indian Company to get drug manufacturing licenses for critical tests in both rapid and Elisa formats like HIV, HBV, HCV  Introduced the technology of differential detection of HIV 1 and HIV 2 in single rapid kit format, a product which still is the market leader after two decades.  Dengue Day 1 test (world-class IVD product) which have achieved no. 1 market share after its launch in 2010  Recently introduced Fluorescence Immunoassay technology for quantitative and qualitative range of tests. The company manufactures HbA1c, Vitamin D, T3, T4, TSH and Dengue NS1 in FIA (Fluorescence immunoassay) range. These tests can be performed on state of the art analyser called i-Quant, developed in partnership with HTIC, IIT Madras. Awards & Recognitions  “India’s Patent King” to its chairman Mr Lalit Mahajan

Company Information

Industry
Biotechnology
Company Type
Privately Held
Founded
unknown
Employee Range
51-200
Revenue Range
Not available

Location

Address
Okhla Industrial Phase 1 Road Delhi New Delhi
City
Ahmedabad
Region
Gujarat
Postal Code
110020
Country
India

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions